Background
==========

Colorectal cancer (CRC) is a common malignant tumor that is one of the leading causes of cancer-related death worldwide \[[@b1-medscimonit-26-e923559]\]. In developed Western countries, CRC is the second most common cancer, and morbidity and mortality rates are continually increasing in China \[[@b2-medscimonit-26-e923559]\]. The onset of CRC is subtle, early symptoms are mild or inconspicuous; therefore, many patients are diagnosed in the middle and late stages of CRC, with poor response to treatment unfavorable prognosis. The 5-year survival rate of advanced metastatic CRC is less than 10%, and it has the fifth-highest cancer mortality rate in China. Although is increasing understanding, improved diagnosis, and more effective therapy of CRC, the precise molecular mechanisms underlying disease initiation and progression are complicated and ambiguous. Therefore, it is of great clinical significance to identify biomarkers related to CRC.

miRNAs repress gene expression, mainly by direct interaction with the 3′-untranslated regions (3′UTRs) of mRNAs, and belong to a cluster of highly conserved, small, non-coding RNAs \[[@b3-medscimonit-26-e923559]\]. miRNAs can serve as either tumor oncogenes or inhibitors, and take part in many biological processes, including cell proliferation, differentiation, and apoptosis, by targeting various transcripts, and are associated with the initiation, promotion, and development of all types of human cancer \[[@b4-medscimonit-26-e923559]\]. With the development of molecular genetics, growing evidence proved that miR-20a is expressed at higher levels in CRC tissues than in normal adjacent mucosal tissues, and patients with elevated expression levels of miR-20a have larger lymph nodes. The high incidence of distant metastasis suggests that miR-20a can regulate the metastasis of CRC. Li et al. indicated that the level of miR-20a was considerably higher in CRC tissues and is correlated with the apoptosis and distant metastasis of cancer cells. Additionally, miR-20a plays a role in migration, invasion, and epithelial-to-mesenchymal transition (EMT) of CRC cells by regulating the underexpression E-cadherin and overexpression of vimentin. However, the mechanism through which miR-20a affects the development of CRC is unclear.

In the present work, integrated analyses were performed and miR-20a was screened as an oncogenic molecule in CRC, suggesting that the level of miR-20a was upregulated in CRC cells and tissues. The overexpressed miR-20a positively regulated cell proliferation and colony formation. Additionally, Foxj2 was identified as a hub target of miR-20a based on the integrated bioinformatics analysis and *in vitro* experiments. Subsequently, the regulation of miR-20a on Foxj2 was also verified, showing that cell migration and invasion were promoted by miR-20a by suppressing the expression of Foxj2.

Material and Methods
====================

Integrated analysis of CRC miRNA and mRNA datasets
--------------------------------------------------

The gene and miRNA expression data and the relevant clinical information of TCGA-COAD were extracted from The Cancer Genome Atlas (TCGA) database in April 2019. The EdgeR package was used to estimate differentially expressed miRNA between CRC tissues and normal tissues. \|logFC\| \>1 and FDR \<0.001 were deemed to be statistically significant. We also identified the cluster of differently expressed miRNAs and mRNAs based on the "pheatmap" package in R.

Prediction of miR-20a targets and enrichment analysis
-----------------------------------------------------

The potential targets of miR-20a were identified based on the intersection of 3 online databases: miRTarBase \[[@b5-medscimonit-26-e923559]\], miRDB \[[@b6-medscimonit-26-e923559]\], and TargetScan \[[@b6-medscimonit-26-e923559]\]. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were conducted using the clusterProfiler package \[[@b7-medscimonit-26-e923559]\]. The correlation between miR-20a and Foxj2 was assessed and plotted using the online starBase \[[@b8-medscimonit-26-e923559]\].

Tissue specimens and cell culture
---------------------------------

Paired CRC tissues and its tumor-adjacent tissues were acquired from patients undergoing radical resection at the First People's Hospital of Jingmen from 2015 to 2016. We randomly selected 24 patients, and the study was approved by the Ethics Committee of the First People's Hospital of Jingmen.

The human CRC cell lines SW480, SW620, HCT-116, and HCT-8, as well as the normal intestinal epithelial cell line FHC, were obtained from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China). RPMI-1640 (Gibco, Carlsbad, CA, USA) with 10% fetal bovine serum (FBS, Gibco) was used to culture the SW480 and HCT-8 cells in a humidified atmosphere with 5% CO~2~ at 37°C. SW620 and HCT-116 cells were incubated in DMEM (Gibco) containing 10% FBS (Gibco) with the same conditions.

Western blot analysis
---------------------

Total proteins were separated from the CRC tissues and cells. The concentrations of proteins were identified based on the Bio-Rad protein assay system (Bio-Rad, Hercules, CA, USA). SDS polyacrylamide gel electrophoresis (SDS-PAGE) was used to analyze the proteins, which were then transferred to PVDF membranes (Millipore). Then, the membrane proteins were subjected to immunoblotting with appropriate antibodies following the instructions of the manufacturer. The protein bands were visualized and quantified.

Real-time quantitative PCR
--------------------------

TRIZOL reagent (Invitrogen) was used to isolate total RNA from frozen tumor tissues and cells. We used the cDNA Synthesis Kit (Takara, Tokyo, Japan) for synthesis of cDNA. The qPCR for miRNAs and mRNA was conducted with specific primers following the instructions of the manufacturer (Life Technologies, Carlsbad, CA, USA). QPCR results of miRNA and mRNA were expressed corresponding to U6 snRNA or β-actin mRNA, respectively. The sequences of the primers were:

1.  Foxj2: 5′-TATGGTAGGGCATGAGGACAAC-3′ (forward),

    5′-GCAAACAATTAAAGGAGGACAAAC-3′ (reverse);

2.  β-actin: 5′-TAGTTGCGTTACACCCTTTCTTG-3′ (forward),

    5′-GCTGTCACCTTCACCGTTCC-3′ (reverse);

3.  miR-20a: 5′-ACACTCCAGCTGGGTAAAGTGCTTATAGTGCA-3′ (forward),

    5′-TGGTGTCGTGGAGTCG-3′ (reverse);

4.  U6: 5′-CTCGCTTCGGCAGCACA-3′ (forward),

    5′-AACGCTTCACGAATTTGCGT-3′ (reverse).

Establishment and transfection of plasmid
-----------------------------------------

The overexpression of miR-20a was performed by transfecting a miR-20a mimic with a synthesized double-stranded RNA oligonucleotide imitating the miR-20a precursor. The synthesized miR-20a mimic and the random negative control RNAs (control mimic and inhibitor) were obtained from GenePharma (Shanghai, China). For overexpression of endogenous Foxj2, the coding sequence of Foxj2 was amplified and subcloned into the pcDNA3.1(+) vector (Invitrogen, Carlsbad, CA, USA) according to the manufacturer' instructions. The empty plasmid was used as the negative control (control plasmid). The overexpressed plasmids were transfected into the cells by Lipofectamine 2000 (Invitrogen) based on the protocols.

Luciferase reporter assay
-------------------------

HCT-116 cells were seeded in 24-well plates with a density of 1×10^5^ cells/well, which were further incubated for 24 h prior to transfection. When performing the reporter gene experiments, 0.5 μg of pGL3-Foxj2-3′UTR or pGL3-Foxj2-3′UTR Mut plasmid, 0.05 ng of the pRL-TK control vector (Promega, USA), and 100 nM miR-20a or the control RNA were used to collectively transfect the cells based on Lipofectamine 2000 (Invitrogen, USA). The Dual-Luciferase Reporter Assay kit (Promega) was used to explore the luciferase activities based on the instructions of the manufacturer. The normalization was assessed by the Renilla luciferase activity.

Transwell assay
---------------

Cell migratory and invasive capacities were determined by transwell chamber assay (BD Biosciences). The transfected cells were collected 24 h after transfection. Subsequently, 3.0×10^5^ transfected cells or control cells were added to every upper insert in the serum-free medium. We added 500 μL culture medium supplemented with 10% FBS to the lower chamber. After the cultivation, non-migrated and non-invaded cells were discarded from the top surface of the transwell membrane using a cotton swab, and the cells remaining on the substrate were fixed with methanol, stained with 0.1% crystal violet, and photographed and counted. The above experiments were conducted in triplicate with biological samples.

Cell cycle analysis
-------------------

Cell cycle analysis was conducted after 48 h of the miRNA transfection based on flow cytometry. Briefly, 2×10^6^ cells were harvested and trypsinized, re-suspended in ethanol, and stored at 4°C for 15 min. Afterward, cells were centrifuged and re-suspended in 450 μL PBS and 50 μL RNase A at 37°C for 30 min. Cells were then treated with propidium iodide (PI, 50 μg/mL) and were cultured for 30 min in the dark at room temperature. Cell cycle analysis was achieved on a FACScan flow cytometer (BD Biosciences) using ModFit LT software.

Cell apoptosis
--------------

The Annexin V-FITC/PI staining kit (BD Biosciences, San Diego, CA, USA) was used for cell apoptosis. HCT-116 cells were seeded in 6-well plates with a density of 10^6^ cells/mL. After transfecting for 24 h, Annexin V-FITC was used to label the cells for 20 min in the darkness. In total, 50 μg/mL of PI was added and further incubated for 30 min. Cell apoptosis was detected to calculate the percentage of cell death based on flow cytometry with the FACScan flow cytometer (BD Biosciences). All tests were performed in triplicate.

Cell proliferation and colony formation assay
---------------------------------------------

For cell proliferation, cell viability was assessed by the MTT assay, in which 3.0×10^3^ cells per well were seeded in 24-well plates and cultured in complete medium. Subsequently, cells were treated with 20 μL MTT (5 mg/mL) and cultured for 4 h. After discarding the medium, the formazan crystals were re-suspended in dimethylsulfoxide (DMSO) and the absorbance was immediately assessed using a microplate reader at 490 nm. For the colony formation assay, 1×10^3^ cells were seeded in 6-well culture plates and cultured in complete culture medium. After culturing for 15 days, 3.7% methanol was applied to fix the colonies of living cells, 0.1% crystal violet was applied for staining, and cell colonies were counted. Colonies consisting of at least 50 cells were scored. All the above experiments were conducted in triplicate.

Xenograft study
---------------

For *in vivo* analyses, cells (1×10^6^) were suspended in 100 μL serum-free DMEM and subcutaneously injected into the flanks of BALB/c male nude mice (3--4 weeks old). For each group, 5 mice were included. The development of tumors in mice was observed every 3 days. Four weeks later, the mice were euthanized and the tumors were removed and photographed, and the volumes were calculated based on the following formula: length (mm)×width^2^ (mm^2^)/2.

Statistical analysis
--------------------

Univariate Cox proportional hazards regression analysis was performed for the identification of candidate genes closely associated with survival. Of the screened genes, the candidates with *p*-value \<0.001 were further subjected to multivariate Cox proportional hazards regression analysis to select the prognostic gene markers. SPSS 17.0 software (SPSS, Chicago, IL) was used for all the statistical analyses. The results are expressed as mean±standard deviation with no less than 3 biological repeats. The comparison between the 2 groups was performed by *t* test. One-way ANOVA was used to assess the significance of variations in different groups. *P*-values \<0.05 were deemed to be statistically significant.

Results
=======

miR-20a was overexpressed in CRC and upregulated cell proliferation and colony formation
----------------------------------------------------------------------------------------

The statistical software R and EdgeR packages were used to identify the differentially expressed microRNAs between control and tumor tissues. [Figure 1A](#f1-medscimonit-26-e923559){ref-type="fig"} displays the volcano plot. All of the altered miRNAs expressed in CRC tissues were identified ([Figure 1B](#f1-medscimonit-26-e923559){ref-type="fig"}), showing that the expression of miR-20a was higher in CRC. RT*-*qPCR analysis showed that the levels of miR-20a were elevated in 4 CRC cell lines -- SW480, SW620, HCT-8, and HCT-116 -- compared with the normal cell line FHC ([Figure 1C](#f1-medscimonit-26-e923559){ref-type="fig"}). Additionally, it was revealed in [Figure 1D](#f1-medscimonit-26-e923559){ref-type="fig"} that the level of miR-20a expressed in CRC tissues was higher in CRC tissues than in the relevant para-carcinoma tissues.

To further explore the roles of miR-20a in the development of CRC, MTT and colony formation assays were performed *in vitro*. miR-20a was overexpressed in HCT-116 cells transfected with miR-20a mimics ([Figure 1E](#f1-medscimonit-26-e923559){ref-type="fig"}). MTT assay showed that cell proliferation was facilitated by overexpression of miR-20a ([Figure 1F](#f1-medscimonit-26-e923559){ref-type="fig"}). Colony formation assay showed that overexpression of miR-20a facilitated the colony-forming ability of HCT-116 cells ([Figure 1G](#f1-medscimonit-26-e923559){ref-type="fig"}). The number of colonies developed from cells treated with miR-20a mimics was counted, which was dramatically higher than that of scramble or control cells (\* P\<0.05).

Identification of miR-20a candidate target genes
------------------------------------------------

To assess the abnormal regulation of miR-20a on CRC, the potential mRNA targets of miR-20a were obtained by the verified target module of miRDB, miRTarBase, and TargetScan databases. Eventually, 120 candidates were selected from these 3 databases. Univariate Cox regression analysis and stepwise multivariate Cox regression analysis were performed to assess the relationship between differentially expressed genes and the overall survival of patients with CRC. As represented in [Supplementary Table 1](#s1-medscimonit-26-e923559){ref-type="supplementary-material"}, 228 downregulated genes with *p*-value \<0.001 were considered as the prognostic candidates, which were chosen for the next screening. To authenticate the reliable target genes, the intersection of promising miR-20a target genes and 228 reduced differentially expressed genes were extracted, which eventually screened out 3 target genes (FOXJ2, CRY2, and PLS1), among which, FOXJ2 has never been previously studied in CRC ([Figure 2A](#f2-medscimonit-26-e923559){ref-type="fig"}).

We assessed the correlation between miR-20a and the candidates using the combination of GO analysis and KEGG pathway analysis. GO enrichment results ([Figure 2B](#f2-medscimonit-26-e923559){ref-type="fig"}) suggested that the activation of MAPKK was the most enriched pathway. The KEGG results ([Figure 2C](#f2-medscimonit-26-e923559){ref-type="fig"}) suggested that the candidates are generally involved in development of a variety of cancers and EGFR tyrosine kinase inhibitor resistance. Moreover, we also developed the expression heatmap for all potential target genes of miR-20a ([Figure 2D](#f2-medscimonit-26-e923559){ref-type="fig"}). The GEPIA database also verified that the Foxj2 expression was inhibited in tumors in comparison with normal tissues ([Figure 2E](#f2-medscimonit-26-e923559){ref-type="fig"}). The results of starBase ([Figure 2F](#f2-medscimonit-26-e923559){ref-type="fig"}) suggested that the level of Foxj2 was negatively correlated with that of miR-20a.

Foxj2 serves as the direct target of miR-20a in CRC cells
---------------------------------------------------------

To sequentially identify the putative target gene of miR-20a in CRC, Foxj2 was utilized as a possible target gene of miR-20a ([Figure 3A](#f3-medscimonit-26-e923559){ref-type="fig"}). To further confirm Foxj2 as a target of miR-20a, the miR-20a binding site was speculated to be in the 3′UTR of Foxj2 mRNA, which was cloned into the dual-luciferase reporter vector. Subsequently, either miR-20a or the negative control RNA with the dual-luciferase expression vector including wild-type or mutant 3′UTR fragment of Foxj2 was co-transfected. Dual-luciferase reporter assay was performed to validate that the luciferase activity of the wild-type Foxj2 3′-UTR luciferase complex rather than the mutant Foxj2 3′UTR was dramatically suppressed by the overexpressed miR-20a ([Figure 3B](#f3-medscimonit-26-e923559){ref-type="fig"}) (P\<0.05). The above results show that Foxj2 directly interacts with miR-20a. In addition, miR-20a was transfected to the HCT-116 cells, and the results of Western blot analyses proved that the miR-20a treatment markedly inhibited Foxj2 expression at the protein level, as indicated in [Figure 3C](#f3-medscimonit-26-e923559){ref-type="fig"}.

Additionally, we performed Western blot and qPCR assays to validate the levels of Foxj2 protein and mRNA in 24 freshly collected CRC tissues and para-carcinoma tissues. Foxj2 was found to be markedly downregulated in 18 of the 24 cases, in contrast to the para-carcinoma tissues (P\<0.05); [Figure 3D](#f3-medscimonit-26-e923559){ref-type="fig"} shows 5 representative pairs. In comparison with the corresponding para-carcinoma tissues, underexpression of Foxj2 mRNA was observed in the CRC tissues based on qPCR analysis (P\<0.05) ([Figure 3E](#f3-medscimonit-26-e923559){ref-type="fig"}). Furthermore, the expression of Foxj2 was negatively correlated with miR-20a expression ([Figure 3F](#f3-medscimonit-26-e923559){ref-type="fig"}).

Foxj2 partially reversed the effects of miR-20a-mediated CRC progression
------------------------------------------------------------------------

To verify whether miR-20a exerted a biological role in CRC progression via targeting Foxj2, HCT-116 cells were collectively transfected with miR-20a mimics and the Foxj2-overexpressed plasmid. As represented in [Figure 4A](#f4-medscimonit-26-e923559){ref-type="fig"}, the MTT assay indicated that the miR-20a-mediated HCT-116 cell proliferation could be reversed by overexpressed Foxj2. Furthermore, it was indicated in [Figure 4B](#f4-medscimonit-26-e923559){ref-type="fig"} that the upregulated Foxj2 expression partially alleviated the effects of the miR-20a-accelerated S phase and induced cell cycle arrest at the G1 stage. Furthermore, [Figure 4C](#f4-medscimonit-26-e923559){ref-type="fig"} revealed the results of flow cytometry analysis, indicating that the apoptosis rate of HCT-116 cells was inhibited by miR-20a mimics and miR-20a with Foxj2-overexpressed plasmid in contrast to the NC group (P\<0.05).

Colony formation and transwell assays revealed that the promotional roles of miR-20a on cell growth, migration, and invasion of HCT-116 cells could be reversed by the overexpression of Foxj2 ([Figure 5A, 5B](#f5-medscimonit-26-e923559){ref-type="fig"}). It was demonstrated in [Figure 5C](#f5-medscimonit-26-e923559){ref-type="fig"} that the reversion of the impacts of miR-20a in tumor development of HCT-116 cells *in vivo*. GO and KEGG enrichment analysis results also suggested that the positively regulated EGFR/AKT pathway induced by miR-20a could be inhibited by the overexpression of Foxj2, indicating that the signaling pathway proteins could serve as the downstream regulation factors of Foxj2 ([Figure 5D](#f5-medscimonit-26-e923559){ref-type="fig"}). Overall, our results suggest that the progression of CRC cells was promoted by miR-20a via modulating Foxj2 *in vitro* and *in vivo*.

Discussion
==========

miR-20a is a member of the miR-17-92 group and is located in the 13q31.1 region. Sequencing data demonstrated that the level of miR-20a was dramatically higher in the CRC cells than in the normal cells, suggesting that miR-20a is positively associated with cell proliferation and colony formation. GO analysis and KEGG pathway analysis showed that Foxj2, as the tumor suppressor gene, targeted miR-20a in CRC. Further research shows that there is a binding site of the 3′ UTR of Foxj2 with miR-20a in CRC. Analyses of miR-20a and Foxj2 protein expression levels in human CRC tissues were negatively associated with each other. Flow cytometry analysis showed that the overexpressed Foxj2 participates in the regulation of CRC development by miR-20a. By decreasing the Foxj2 levels, miR-20a facilitates the proliferation of colorectal cells, but the flow pattern suggests that miR-20a/Foxj2 does not play a in apoptosis *in vivo*. Further, *in vitro* and *in vivo* experiments have revealed that overexpression of Foxj2 can effectively reverse the cancer-promoting effects of miR-20a. The above data broadened the horizon for the new regulatory network targeted miR-20a and Foxj2 in CRC, and show the specific mechanism by which miR-20a promotes CRC.

Previous research reported that miR-20a was decreased in several solid tumors, like breast cancer \[[@b9-medscimonit-26-e923559]\] and pancreatic carcinoma \[[@b10-medscimonit-26-e923559]\], but miR-20a is a broadly overexpressed oncogene in various tumors, including anaplastic thyroid cancer \[[@b11-medscimonit-26-e923559]\], lung cancer \[[@b12-medscimonit-26-e923559]\], prostate cancer \[[@b13-medscimonit-26-e923559]\], esophageal squamous cell carcinoma \[[@b14-medscimonit-26-e923559]\], gliomas \[[@b15-medscimonit-26-e923559]\], and colon adenocarcinoma \[[@b16-medscimonit-26-e923559]\], suggesting that the expression and role of miR-20a vary in different tumor types. It has been clearly indicated that the abilities of cell proliferation, invasion, and tumor metastasis in breast cancer cells are suppressed by overexpression of miR-20a \[[@b17-medscimonit-26-e923559]\]. In contrast, miR-20a was observed to inhibit the proliferation and metastasis of the cells of pancreatic carcinoma via directly reducing Stat3 \[[@b10-medscimonit-26-e923559]\]. Other reports indicated that overexpression of miR-20a facilitates the proliferation of ovarian cancer cells and the migration and invasion in the cells of cervical cancer, ovarian cancer and osteosarcoma \[[@b18-medscimonit-26-e923559]--[@b20-medscimonit-26-e923559]\], implying that miR-20a acted as the onco-miR. The present study demonstrates that miR-20a is upregulated in CRC tissues, which agrees with the combined detection of TCGA and validation of qPCR. Additionally, miR-20a increased the proliferation and colony-forming ability of CRC cells. Hence, it may be concluded that the deregulation of miR-20a functions as a carcinogenic miRNA and is involved in the progression of CRC. Previous studies showed the crucial effects of miRNAs on the genesis and progression of tumors through regulating the levels of target genes \[[@b21-medscimonit-26-e923559]\]. To verify the bioinformatics analysis for predicting the potential biomarkers of CRC, the screened candidate gene Foxj2 was further validated. Our data also proved that Foxj2 was directly targeted to miR-20a in the CRC cells.

The genes associated with differentiation, apoptosis, proliferation, metabolism, migration, and invasion were reported to be modulated by the Forkhead box (FOX) transcription factor family \[[@b22-medscimonit-26-e923559],[@b23-medscimonit-26-e923559]\]. Forkhead box j2 (Foxj2), belonging to the Forkhead box transcription factor family \[[@b24-medscimonit-26-e923559]\], which exists in several mammals and other vertebrates \[[@b25-medscimonit-26-e923559]--[@b27-medscimonit-26-e923559]\], is widely distributed in different organs and tissues of adults and in fetuses. More importantly, recent studied showed that Foxj2 may participate in tumorigenesis \[[@b28-medscimonit-26-e923559]\]. Foxj2 regulates the process of cell migration and cell cycle \[[@b29-medscimonit-26-e923559],[@b30-medscimonit-26-e923559]\]. For example, some observations indicated that elevated Foxj2 inhibits cell migration and invasion of glioma and is positively associated with E-cadherin \[[@b31-medscimonit-26-e923559]\]. In addition, Foxj2 may contribute to the development of EMT via the Notch signaling pathway in non-small cell lung cancer \[[@b32-medscimonit-26-e923559]\]. In the present work, integrated bioinformatics analyses and experiments showed that Foxj2 serves as a tumor inhibitor in CRC. In line with the above results, we found that the migration and invasion of CRC is facilitated by miR-20a via inhibiting Foxj2. These findings show the strong correlation between miR-20a and the Foxj2 axis, which has a significant impact on cell proliferation and tumorigenesis.

Conclusions
===========

This is the first study to demonstrate that CRC tumorigenesis is promoted by targeting of miR-20a with Foxj2. Further results on miR-20a/Foxj2 axis will offer a promising target and open the way for new CRC molecular therapeutics. Nevertheless, it is not clear how Foxj2 influences CRC progression. Hence, further studies are needed to elucidate the effects and functions of Foxj2 in CRC cells.

Supplementary Data
==================

###### 

Prognostic value of the target genes in CRC patients of the TCGA cohort.

  Gene symbol   Univariate analysis   Multivariate analysis             
  ------------- --------------------- ----------------------- --------- ---------
  ZNF133        1.537498631           0.008697705             38        \<0.001
  ZKSCAN2       1.691982256           0.004876581             8.9       \<0.001
  ZDHHC11       1.183004595           0.006286627             3.2e-01   \<0.001
  WSB2          0.467109344           0.003950621             25        \<0.001
  WDR86         1.40240492            0.006044641             72        \<0.001
  VDAC1         0.531016786           0.006341117             2.7e-03   \<0.001
  USH1G         1.260619617           0.001234788             2.1       \<0.001
  TRIM25        0.573345214           0.007816236             2.2e-01   \<0.001
  TREX2         1.373224848           0.002772185             16        \<0.001
  TRABD2B       1.285006739           0.002930684             6.0e-01   \<0.001
  TMEM81        1.644187505           0.008760967             1.6e-01   \<0.001
  ZKSCAN2       1.691982256           0.004876581             8.9       \<0.001
  ZDHHC11       1.183004595           0.006286627             3.2e-01   \<0.001
  WSB2          0.467109344           0.003950621             25        \<0.001
  WDR86         1.40240492            0.006044641             72        \<0.001
  VDAC1         0.531016786           0.006341117             2.7e-03   \<0.001
  USH1G         1.260619617           0.001234788             2.1       \<0.001
  TRIM25        0.573345214           0.007816236             2.2e-01   \<0.001
  TREX2         1.373224848           0.002772185             16        \<0.001
  TRABD2B       1.285006739           0.002930684             6.0e-01   \<0.001
  TMEM81        1.644187505           0.008760967             1.6e-01   \<0.001
  TMEM165       0.586600114           0.007386349             1.1e-02   \<0.001
  TMCC2         1.576746915           0.000688545             8.9e-02   \<0.001
  TINAG         0.862994088           0.00425559              2.9e-01   \<0.001
  TGM6          1.219997455           0.004782644             5.1e-01   \<0.001
  TCF7L1        1.520206387           0.000495012             5.9       \<0.001
  TCEAL5        1.213662999           0.004119467             3.7e-01   \<0.001
  TCAIM         0.572670505           0.003588079             1000      \<0.001
  SUSD5         1.232270257           0.003620369             5.0e-01   \<0.001
  STK32C        1.40872781            0.005501541             8.4e-02   \<0.001
  SRPX          1.241306378           0.001854167             2.9       \<0.001
  SOX7          1.372226734           0.003493233             1.1e-01   \<0.001
  SOWAHA        0.738552315           0.000853741             3.4e-01   \<0.001
  SNCB          1.457793587           1.65609E-05             7.1       \<0.001
  SLITRK2       1.251506902           0.001222424             5.3e-01   \<0.001
  SLC6A17       1.288351213           0.00255427              6.1e-01   \<0.001
  SLC38A8       1.288767274           0.00473397              1.7       \<0.001
  SLC28A2       0.88596792            0.006146815             2         \<0.001
  SLC20A2       0.63283218            0.009266251             6.6e-02   \<0.001
  SLC16A8       1.352969047           0.00026993              2.7e-01   \<0.001
  SIX2          1.162090077           0.001996522             2.6       \<0.001
  SIN3B         1.914175669           0.007211485             7.5       \<0.001
  SHQ1          0.45559615            0.009472777             35        \<0.001
  SH3GL3        1.352516953           0.003004732             1.6e-01   \<0.001
  SH3D19        0.656860309           0.00634363              3.0e-01   \<0.001
  SGK2          0.83804645            0.00294523              2.7e-01   \<0.001
  SEZ6L2        1.435716471           0.001675202             8.2       \<0.001
  SEMA6C        1.610116899           0.000195179             4.8       \<0.001
  SCN3B         1.215243964           0.005809295             3.5e-01   \<0.001
  SBK2          1.681191002           4.28891E-05             1.1e-01   \<0.001
  SACS          1.295055049           0.009934617             4         \<0.001
  S100P         0.847861221           0.004546645             4.0e-01   \<0.001
  RUBCNL        0.854620542           0.007175531             5         \<0.001
  RTN4RL2       1.262078269           0.009330644             3.4e-01   \<0.001
  RTL5          1.305462946           0.004553238             75        \<0.001
  RORC          0.810066461           0.004513852             6.7e-01   \<0.001
  RNF43         0.794265928           0.003920463             1.0e-01   \<0.001
  RBP7          1.409275162           0.000394274             2.3e-01   \<0.001
  RBM3          0.676121381           0.008539379             1.3e-01   \<0.001
  RBM17         2.414924435           0.007712655             6800      \<0.001
  QRICH2        1.481967745           0.002424447             5.8       \<0.001
  PTH1R         1.271139463           0.001344702             3.8       \<0.001
  PRRT4         1.200187997           0.001213094             3.6e-01   \<0.001
  PRRT1         1.376312756           0.009195431             8.1       \<0.001
  PRELID2       0.639356718           0.002758224             32        \<0.001
  PPP2CB        0.591469544           0.009534317             2.7e-03   \<0.001
  PPFIA4        1.293115792           0.003103059             8.4       \<0.001
  PPARGC1A      0.834950723           0.001527893             1.9e-01   \<0.001
  POFUT2        2.049110498           0.005309024             3.2e-02   \<0.001
  PMM2          0.437645266           0.000311294             3000      \<0.001
  PMCH          0.643781405           0.003027112             2.2e-01   \<0.001
  PLS1          0.666294786           0.00375481              6.7       \<0.001
  PLPP2         0.641212973           0.001072941             7.6e-04   \<0.001
  PLEKHG4B      1.302343681           0.000505889             1.1e-01   \<0.001
  PIP5K1C       1.716568911           0.006747328             2.6e-01   \<0.001
  PDZD4         1.17293216            0.007277794             2.3       \<0.001
  PDE1B         1.316236541           0.002107239             2.6e-01   \<0.001
  PDCD6IP       0.554647065           0.009870352             260       \<0.001
  PCDHB8        1.143959444           0.008713351             5.5e-01   \<0.001
  PAGE1         1.173634426           0.004839683             2.9e-01   \<0.001
  OVOL3         1.315953982           0.008292592             1.6       \<0.001
  OR2B6         1.299546249           0.009721983             6.9e-01   \<0.001
  OAZ2          2.842306103           0.002254038             110       \<0.001
  NXPE3         1.434379996           0.008906926             8.2e-03   \<0.001
  NPTXR         1.209880744           0.002997987             3.8e-01   \<0.001
  NPR2          1.585561158           0.005736431             1.8e-02   \<0.001
  NPR1          1.267838515           0.008905722             1.8e-01   \<0.001
  NLGN1         1.176341275           0.001783991             2.5       \<0.001
  NHLRC4        1.551869878           0.000643194             74        \<0.001
  NGFR          1.200989542           0.001532476             1.4e-01   \<0.001
  NGF           1.318819479           0.004309054             2.5e-01   \<0.001
  NFATC1        1.307619018           0.007598954             46        \<0.001
  NECAB2        1.27076126            0.006135428             4.9       \<0.001
  NCKAP5L       2.169171268           2.56373E-05             3.1e-02   \<0.001
  NAT1          0.73284881            0.006734646             3.9       \<0.001
  NACAD         1.305822623           0.00141327              48        \<0.001
  MYB           0.630652971           0.002410283             4.9e-01   \<0.001
  MMAA          0.576201489           0.001516101             2.9       \<0.001
  MLLT11        1.34614653            0.006077126             26        \<0.001
  MKRN2OS       0.654012218           0.001024618             1.6e-01   \<0.001
  METTL9        0.538908907           0.009335042             1.3e-01   \<0.001
  MC1R          1.29905193            0.006969694             1.4e-01   \<0.001
  MAPKAPK5      0.470290813           0.00753356              490       \<0.001
  MAPK12        1.3737705             0.00094184              18        \<0.001
  MAGEF1        1.956272182           0.007680343             3.4e-04   \<0.001
  MAGEA1        1.247064893           2.7493E-05              3.3       \<0.001
  LRP2          1.288962734           6.10532E-05             1.5       \<0.001
  LINGO1        1.355302198           0.000399767             4.6e-01   \<0.001
  LEP           1.18500816            0.002465145             12        \<0.001
  MMAA          0.576201489           0.001516101             2.9       \<0.001
  MLLT11        1.34614653            0.006077126             26        \<0.001
  MKRN2OS       0.654012218           0.001024618             1.6e-01   \<0.001
  METTL9        0.538908907           0.009335042             1.3e-01   \<0.001
  MC1R          1.29905193            0.006969694             1.4e-01   \<0.001
  MAPKAPK5      0.470290813           0.00753356              490       \<0.001
  MAPK12        1.3737705             0.00094184              18        \<0.001
  MAGEF1        1.956272182           0.007680343             3.4e-04   \<0.001
  MAGEA1        1.247064893           2.7493E-05              3.3       \<0.001
  LRP2          1.288962734           6.10532E-05             1.5       \<0.001
  LINGO1        1.355302198           0.000399767             4.6e-01   \<0.001
  LEP           1.18500816            0.002465145             12        \<0.001
  KCNIP3        1.260837142           0.004916884             4.7e-02   \<0.001
  ITIH6         1.209106013           0.002657523             7.3       \<0.001
  ITGA5         1.307298059           0.005855555             990       \<0.001
  IRX6          1.322112702           0.000843443             3.3e-01   \<0.001
  IQSEC3        1.27677672            0.004666794             1.9e-01   \<0.001
  INHBB         1.177779802           0.004605681             31        \<0.001
  HTR2C         1.227695273           0.002343627             3.7       \<0.001
  HRASLS5       1.169770556           0.008070109             5.0e-01   \<0.001
  HPD           1.334359324           0.004019401             2.3       \<0.001
  HPCAL4        1.283814727           0.00451649              6.7       \<0.001
  HOXC6         1.181620432           0.000133735             3.3e-01   \<0.001
  HOXC13        1.204636727           0.000531529             2.5       \<0.001
  HEYL          1.676211788           0.000538317             4.5       \<0.001
  HEY1          1.587051358           0.002290132             2.4e-01   \<0.001
  HEXB          0.461726956           0.000952528             120000    \<0.001
  HDAC7         1.96210524            0.006035858             110000    \<0.001
  GSPT1         0.489079951           0.005568086             1.2e-05   \<0.001
  GRIK5         1.183858849           0.008746472             5.7e-01   \<0.001
  GRID1         1.336945729           0.00449767              3.1       \<0.001
  GPRC5B        1.535508947           0.000501917             13        \<0.001
  GPRASP1       1.272720263           0.006263557             6.4e-02   \<0.001
  GPR156        1.308364429           0.001153267             4.2       \<0.001
  GLYATL1       0.860613222           0.006528162             9.5e-02   \<0.001
  GDF15         0.833412966           0.008604588             1.4       \<0.001
  GAREM2        1.381779663           0.005033009             1.6       \<0.001
  GALNT15       1.204296146           0.008635526             1.4e-01   \<0.001
  FZD4          1.486653675           0.006249553             3.6e-03   \<0.001
  FSTL3         1.271624144           0.007962522             1.6e-01   \<0.001
  FOXL2NB       1.345119444           5.39726E-05             4.2       \<0.001
  FOXL2         1.259891809           0.000933203             6.9e-01   \<0.001
  FOXJ2         2.472932089           0.002849779             1.9e-01   \<0.001
  FOXD4         1.245464377           0.005531115             3.8       \<0.001
  FOXC1         1.270115339           0.002834468             5.4e-01   \<0.001
  FNDC5         1.332360452           0.001709798             2.6       \<0.001
  FLT3LG        1.417336731           0.009536758             1.8e-02   \<0.001
  FES           1.443664395           0.005175721             3.0e-01   \<0.001
  FAM117A       1.562351037           0.009158748             400       \<0.001
  FAM110D       1.383624103           0.002865335             8.1       \<0.001
  FADS1         1.287690981           0.006909719             1.9       \<0.001
  FABP4         1.139559679           0.001160698             4.1e-01   \<0.001
  EXTL1         1.265980039           0.005035667             1.0e-01   \<0.001
  ETS2          0.668284016           0.005916623             7.1       \<0.001
  ERMAP         0.568400341           0.009071429             2.3e-02   \<0.001
  ERICH3        1.230607448           0.006719883             1.9       \<0.001
  EREG          0.887017859           0.006138749             1.5       \<0.001
  EPS8          0.583792225           0.006078897             2.8       \<0.001
  EPO           1.377559357           0.008650002             6.7       \<0.001
  EPHB2         0.722678923           0.009896647             35        \<0.001
  EMC3          0.431853091           0.001771981             23        \<0.001
  EIF2S3B       0.78869205            0.003802776             5.2e-01   \<0.001
  EFHD1         1.390626574           0.001678327             5         \<0.001
  EBF4          1.460934784           0.000259432             4.2       \<0.001
  DRD4          1.302006231           0.004539947             60        \<0.001
  DOCK3         1.289854413           0.002209175             3.0e-01   \<0.001
  DMPK          1.427657686           0.002350812             4.0e-01   \<0.001
  DLG4          1.479923277           0.00994533              1.1e-01   \<0.001
  DHX15         0.392830659           0.000995095             2400      \<0.001
  DCTN1         2.095513206           0.007449317             1.1e-05   \<0.001
  CYP4F12       0.741142308           0.000753205             3.7       \<0.001
  CTNNA1        0.519488852           0.000584074             36        \<0.001
  CTF1          1.248947118           0.007277252             7.2e-01   \<0.001
  EPHB2         0.722678923           0.009896647             35        \<0.001
  CT45A1        1.285770132           0.00881524              4.3e-02   \<0.001
  CRY2          1.862665669           0.003229067             2.9e-02   \<0.001
  CRISPLD2      1.347498521           0.008331665             1.9e-01   \<0.001
  CORO6         1.314726218           0.002462567             2.1e-01   \<0.001
  CNTNAP1       1.297543992           0.008474966             3.0e-01   \<0.001
  CNPY1         1.279382847           0.005932603             2.4       \<0.001
  CLSTN3        1.648521955           0.004361652             68        \<0.001
  CLRN3         0.690451251           0.000104942             18        \<0.001
  CILP          1.116653758           0.00881835              4.6e-01   \<0.001
  CIDEA         1.157068648           0.004837007             2.2       \<0.001
  CHDH          0.720216727           0.008461958             3.3e-01   \<0.001
  CHD5          1.36465549            0.000340142             1.6       \<0.001
  CHD3          1.568155448           0.007182613             4.3       \<0.001
  CERS1         1.256482733           0.006187944             2.5e-01   \<0.001
  CELF4         1.266315192           0.000502411             3.2       \<0.001
  CEACAM6       0.830447969           0.006481502             4.4       \<0.001
  CDS1          0.619434738           0.00328904              3.2e-01   \<0.001
  CDHR2         0.847514909           0.003798721             2.9       \<0.001
  CDH17         0.729770539           0.000635009             1.4e-01   \<0.001
  CDC25C        0.684151197           0.00688226              8.2       \<0.001
  CCRL2         0.677114592           0.002178477             5.3e-01   \<0.001
  CCNA2         0.676285748           0.00597114              7.3e-04   \<0.001
  CAVIN1        1.354009446           0.004433824             2.7       \<0.001
  CATSPERG      1.370530111           0.007056119             3         \<0.001
  CARNS1        1.264766074           0.00669264              1.5       \<0.001
  CADPS         0.867620712           0.008019302             1.8       \<0.001
  C7            1.154533485           0.000912349             11        \<0.001
  C4orf50       1.306276285           0.009847324             2.2       \<0.001
  C1QL4         1.265743223           0.006675407             3.9e-01   \<0.001
  C19orf81      1.223741881           0.004326188             5.9e-01   \<0.001
  C16orf96      1.331680254           0.005459506             3.9e-01   \<0.001
  BST2          1.245735057           0.002990982             4.0e-01   \<0.001
  BHMG1         1.326825141           0.000415561             7.0e-01   \<0.001
  AXIN2         0.814861386           0.003939369             2.6e-01   \<0.001
  ATP6V1B1      1.397896547           1.29412E-05             1.5e-01   \<0.001
  ATP2A1        1.364043136           0.001518394             15        \<0.001
  ASPG          0.828092956           0.002850215             4.1e-01   \<0.001
  ARV1          0.645960387           0.006296874             160       \<0.001
  ARHGEF17      1.47498475            0.00307932              5         \<0.001
  APELA         0.81227505            0.006766816             5.2e-01   \<0.001
  APC2          1.595680863           0.00064022              61        \<0.001
  AOC2          1.319226342           0.003690611             1.9e-01   \<0.001
  ANKS4B        0.657463731           0.000561344             6.7e-02   \<0.001
  ANKRD22       0.730856239           0.002877536             2.1       \<0.001
  ANAPC5        0.4607465             0.0094694               7.8e-03   \<0.001
  AIF1L         1.281527978           0.003975246             14        \<0.001
  AGMAT         0.701313746           0.009415433             10        \<0.001
  AGFG1         0.471524071           0.008488669             9.8e-04   \<0.001
  ADARB1        1.742317631           0.000124682             1.3e-01   \<0.001
  ADAM9         0.686991601           0.00312403              100       \<0.001
  ADAM11        1.388217427           0.000336073             3.8e-01   \<0.001
  ACOT11        0.679141782           0.004708273             9.4       \<0.001
  AC129492.1    1.368845979           0.002649713             4.9e-02   \<0.001
  AC009336.2    1.302764599           0.000840112             5.8e-01   \<0.001
  CD1A          0.761654995           0.000272979             7.2e-01   0.001
  STARD9        1.264169741           0.008620268             1.4       0.002
  DAPK1         1.249692788           0.008324465             1.3       0.002
  DSG4          0.782143447           0.002206743             1.3       0.003
  TMEM88        1.561816138           0.000335998             6.6e-01   0.005
  FAM151B       0.623891263           0.00218039              6.1e-01   0.005
  SYCE2         1.308137768           0.009435619             7.1e-01   0.007
  JPH3          1.233591685           0.004498381             8.0e-01   0.008
  JDP2          1.704624037           0.00979684              5.3e-01   0.011
  ZDHHC3        0.40145391            0.000119984             2.2       0.015
  CCL24         0.857409516           0.005718276             8.5e-01   0.015
  ALDOB         0.884387033           0.009297044             1.1       0.019
  RIMKLB        1.264805716           0.009187316             7.6e-01   0.022
  C10orf55      0.753029457           0.008084309             1.3       0.023
  F2RL2         0.82236627            0.00801046              8.3e-01   0.042
  ANXA3         0.767488008           0.002450007             8.0e-01   0.045
  ALPP          1.143185335           0.007108907             1.1       0.045
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![miR-20a expression was upregulated in CRC and overexpression of miR-20a promoted cell growth and colony formation. (**A**) Volcano plot of differentially expressed miRNAs. X-axis: log~2~ (fold change); Y-axis: log~10~ (FDR). Red dots: significantly upregulated genes; Green dots: significantly downregulated genes; Black dots: non-differentially expressed genes. (**B**) The heatmap of the differentially expressed miRNAs between CRC tissues and adjacent normal tissues. Differentially expressed genes in CRC were screened and are presented in the rows, and the columns are samples. The green represents downregulation, while a red represents upregulation. (**C**) The expression of miR-20a was detected in CRC cell lines (SW480, SW620, HCT-8, and HCT-116) and the normal cell line FHC using qPCR analysis. (**D**) qPCR analysis of miR-20a expression levels in 24 pairs of CRC tissues and their corresponding adjacent normal tissues (P\<0.001). (**E**) qPCR analysis was used to evaluate miR-20a expression after transfection with miR-20a mimics or scramble or no transfection (control). (**F**) MTT assay was used to study the proliferation of the HCT-116 cells after transfection with the miR-20a mimics or scramble or control. (**G**) Overexpression of miR-20a promoted the HCT-116 cells colony formation. The relative numbers of colonies are shown in the right. \* P\<0.05; \*\* P\<0.001.](medscimonit-26-e923559-g001){#f1-medscimonit-26-e923559}

![FOXJ2 was predicted to be the target of miR-20a by bioinformatics analysis. (**A**) Venn diagram of 3 overlapping DEGs from differentially expressed mRNAs and predicted miR-20a target genes. (**B, C**) GO analysis and KEGG pathway of predicted miR-20a target genes are shown diagrammatically. (**D**) The heatmap of the predicted miR-20a target genes. Red: high expression level; green: low expression level. (**E**) The expression level of FOXJ2 was validated according to the GEPIA database. (**F**) A significant negative correlation was found between FOXJ2 and miR-20a expression.](medscimonit-26-e923559-g002){#f2-medscimonit-26-e923559}

![Foxj2 is a direct target gene of miR-20a in CRC cells. (**A**) The sequences of miR-20a binding sites within the human Foxj2 3′UTR and schematic reporter constructs. Foxj2-WT represents the reporter constructs containing the entire 3′UTR sequences of Foxj2. Foxj2-MUT represents the reporter constructs containing mutated nucleotides. (**B**) Analysis of relative luciferase activities of Foxj2-WT and Foxj2-MUT. (**C**) Western blot analysis showed that overexpression of miR-20a downregulated the Foxj2 protein level in the HCT-116 cells. (**D**) The expression of Foxj2 protein levels in CRC tissues was established by Western blot (representative results of 5 cases were shown). (**E**) qPCR analyses of Foxj2 expression in CRC and matched adjacent normal tissues. (**F**) The relationship between miR-20a and Foxj2 expression was evaluated by Spearman's correlation analysis of CRC tissues (R^2^=0.476, P\<0.001). \* P\<0.05.](medscimonit-26-e923559-g003){#f3-medscimonit-26-e923559}

![Effects of Foxj2 overexpression on miR-20a-mediated CRC progression. (**A**) MTT analysis was used to detect cell proliferation at various time points after transfection with miR-20a mimic and Foxj2 overexpression plasmid. (**B, C**) Cell cycle and cell apoptosis of HCT-116 cells transfected with miR-20a with and without Foxj2 overexpression were assessed by flow cytometry. \* P\<0.05.](medscimonit-26-e923559-g004){#f4-medscimonit-26-e923559}

![The effects of miR-20a-promoted CRC cell proliferation, migration, and invasion were mediated by the downregulation of Foxj2 *in vitro* and *in vivo*. (**A**) Colony formation assays were used to determine the effects of growth in HCT-116 cells transfected with miR-20a with and without Foxj2 overexpression. The number of colonies was analyzed quantitatively. (**B**) Cell migration and invasion were performed in HCT-116 cells transfected with miR-20a with and without Foxj2 overexpression. Representative images of migrated and invaded cells (magnification ×100) and quantification of migrated and invaded cells per field. (**C**) The proliferation activity of xenograft tumors in HCT-116 cells transfected with miR-20a and Foxj2 overexpression on the average volumes in xenograft tumors. (**D**) The effects of Foxj2 overexpression on the expression of EGFR/AKT signaling pathway proteins in miR-20a-transfected HCT-116 cells were tested by Western blot analysis. \* P\<0.05.](medscimonit-26-e923559-g005){#f5-medscimonit-26-e923559}
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